You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 13, 2024

TRIPTORELIN PAMOATE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for triptorelin pamoate and what is the scope of freedom to operate?

Triptorelin pamoate is the generic ingredient in two branded drugs marketed by Azurity and Verity, and is included in four NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

Triptorelin pamoate has forty-six patent family members in thirty-one countries.

There are two drug master file entries for triptorelin pamoate. Two suppliers are listed for this compound.

Summary for TRIPTORELIN PAMOATE
International Patents:46
US Patents:1
Tradenames:2
Applicants:2
NDAs:4
Drug Master File Entries: 2
Finished Product Suppliers / Packagers: 2
Raw Ingredient (Bulk) Api Vendors: 56
Clinical Trials: 17
Patent Applications: 6,823
What excipients (inactive ingredients) are in TRIPTORELIN PAMOATE?TRIPTORELIN PAMOATE excipients list
DailyMed Link:TRIPTORELIN PAMOATE at DailyMed
DrugPatentWatch® Estimated Loss of Exclusivity (LOE) Date for TRIPTORELIN PAMOATE
Generic Entry Date for TRIPTORELIN PAMOATE*:
Constraining patent/regulatory exclusivity:
Dosage:
INJECTABLE;INTRAMUSCULAR

*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.

Recent Clinical Trials for TRIPTORELIN PAMOATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Cancer Research AntwerpPhase 2
Janssen PharmaceuticaPhase 2
National Cancer Institute (NCI)Phase 1/Phase 2

See all TRIPTORELIN PAMOATE clinical trials

Medical Subject Heading (MeSH) Categories for TRIPTORELIN PAMOATE

US Patents and Regulatory Information for TRIPTORELIN PAMOATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Verity TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Azurity TRIPTODUR KIT triptorelin pamoate FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 208956-001 Jun 29, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Verity TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 022437-001 Mar 10, 2010 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
Verity TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 021288-001 Jun 29, 2001 RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Azurity TRIPTODUR KIT triptorelin pamoate FOR SUSPENSION, EXTENDED RELEASE;INTRAMUSCULAR 208956-001 Jun 29, 2017 RX Yes Yes ⤷  Sign Up ⤷  Sign Up Y ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for TRIPTORELIN PAMOATE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Verity TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 021288-001 Jun 29, 2001 ⤷  Sign Up ⤷  Sign Up
Verity TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000 ⤷  Sign Up ⤷  Sign Up
Verity TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 022437-001 Mar 10, 2010 ⤷  Sign Up ⤷  Sign Up
Verity TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000 ⤷  Sign Up ⤷  Sign Up
Verity TRELSTAR triptorelin pamoate INJECTABLE;INTRAMUSCULAR 020715-001 Jun 15, 2000 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for TRIPTORELIN PAMOATE

Country Patent Number Title Estimated Expiration
Spain 2694401 ⤷  Sign Up
China 101677959 Slow release pharmaceutical composition made of microparticles ⤷  Sign Up
Lithuania 2500014 ⤷  Sign Up
Serbia 55591 FARMACEUTSKA KOMPOZICIJA SA SPORIM OSLOBAĐANJEM PRIPREMLJENA OD MIKROČESTICA (SLOW RELEASE PHARMACEUTICAL COMPOSITION MADE OF MICROPARTICLES) ⤷  Sign Up
Poland 2164467 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.